Steve Elms is Director of Marker Therapeutics, Inc.. Currently has a direct ownership of 29,680 shares of MRKR, which is worth approximately $155,523. The most recent transaction as insider was on Jun 08, 2021, when has been sold 12,658 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.7K
0% 3M change
0% 12M change
Total Value Held $155,523

STEVE ELMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2021
BUY
Grant, award, or other acquisition
-
12,658 Added 29.9%
29,680 Common Stock

Also insider at

ADMA
ADMA BIOLOGICS, INC. Healthcare
ELEV
Elevation Oncology, Inc. Healthcare
ZSANQ
Zosano Pharma Corp
SE

Steve Elms

Director
New York, NY

Track Institutional and Insider Activities on MRKR

Follow Marker Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRKR shares.

Notify only if

Insider Trading

Get notified when an Marker Therapeutics, Inc. insider buys or sells MRKR shares.

Notify only if

News

Receive news related to Marker Therapeutics, Inc.

Track Activities on MRKR